CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Revenues	$ 2,823.8	$ 2,791.2
Cost of Revenue	2,095.8	2,001.5
Gross Profit	728.0	789.7
Selling, general and administrative expenses	395.5	393.8
Amortization of intangibles and other assets	62.3	57.1
Asset Impairment Charges	437.4	0.0
Net restructuring and other special charges	25.4	20.6
Operating Income (Loss)	(192.6)	318.2
Other income (expenses):
Interest expense	(55.0)	(56.7)
Equity method income, net	(6.6)	3.0
Investment income	2.6	0.6
Other, net	(16.1)	(10.4)
Earnings before income taxes	(267.7)	254.7
Provision for income taxes	49.2	68.8
Net earnings	(316.9)	185.9
Less: Net earnings attributable to the noncontrolling interest	(0.3)	(0.3)
Net earnings attributable to Laboratory Corporation of America Holdings	$ (317.2)	$ 185.6
Basic earnings per common share (in dollars per share)	$ (3.27)	$ 1.88
Diluted earnings per common share (in dollars per share)	$ (3.27)	$ 1.86